Live Breaking News & Updates on உலகம் பரந்த பிராந்திய மருத்துவ வாழ்க்கைத்தொழில்கள்

Share:
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research and development experience in academic, government,
in vitro diagnostic and device industry settings.
Dr. Stankovic is currently managing partner at Koliada Consulting, LLC, a firm focused on biotech, medical devices and
in vitro diagnostics. Previously, she was Senior Vice President, World Wide Regional Medical Affairs and Global Health, for Becton, Dickinson and Company (BD). Dr. Stankovic served in senior roles at BD for more than a decade, leading medical affairs and clinical operations for various BD business units. ....

United States , Serbia General , Agnes Lee , Chris Linthwaite , Mark Spearman , University Of Alabama At Birmingham , World Wide Regional Medical Affairs , Public Health , University Of Belgrade , Vanderbilt University School Of Medicine , Division Of Laboratory Systems , Immucor Inc , Centers For Disease , Public Health Practice Program Office , Department Of Pathology At Harvard Medical School , Koliada Consulting , Outcomes Research , Fluidigm Corporation , Global Health , Corporate Communications , Department Of Pathology , Quest Diagnostics , Senior Vice President , Associate Clinical Professor , Vanderbilt University School , Guest Lecturer ,